Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical Prostatectomy [NA]
This clinical trial evaluates the use of confocal microscopy to detect positive surgical margins during radical prostatectomy in patients wi…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer [EARLY_Phase 1]
Early-phase clinical trial evaluating the safety, dosimetry, and efficacy of the radiopharmaceutical 177Lu-FC516 in patients with prostate c…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer [Phase 1, Phase 2]
This entry outlines a Phase 1/2 clinical study evaluating SHR-4394 in combination with anti-tumor therapy for prostate cancer, currently rec…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Collection of Blood From Patients With Cancer
Clinical trial update indicating ongoing recruitment to collect blood samples from patients with cancer for research purposes. The listed co…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread [Phase 1]
Phase 1 study update for BPX-601 CAR T-Cell Therapy in adults with prostate cancer that has recurred, is treatment-resistant, and metastasiz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men [NA]
This clinical trial explores a virtual reality assistant intended to support newly diagnosed Black men with prostate cancer, and the study i…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial [Phase 2]
DIVINE is a Phase 2 trial evaluating stereotactic body radiation therapy with either immediate or delayed androgen receptor pathway inhibito…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer [Phase 1]
This phase 1 trial update reports safety, pharmacokinetics, and preliminary efficacy data for VIR-5500 (AMX-500) in men with hormone-refract…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) [Phase 3]
This clinical trial update notes that the Phase 3 MK-2400-001 study evaluating Ifinatamab Deruxtecan (I-DXd) in metastatic prostate cancer i…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer [Phase 1]
This Phase 1 trial from Genentech evaluates the safety, pharmacokinetics, and activity of RO7656594 in patients with advanced or metastatic …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating PSMA-PET guided de-escalation of salvage radiation therapy in recurrent prostate ca…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Outcomes of Focal Ablation for Prostate Cancer
This clinical trial update shows a recruiting study by UT Southwestern Medical Center evaluating focal ablation as a treatment for prostate …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating orally administered MOMA-313 in adults with advanced or metastatic solid tumors; the study is currently active but …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in combination with 177Lu-PSMA-617 for castration-resistant prostate cancer, including metas…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 [Phase 2]
This entry describes an ongoing Phase II dose-escalation trial using intensity-modulated radiotherapy (IMRT) for high-risk non-metastatic pr…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer [EARLY_Phase 1]
An early-phase trial assesses dosimetry, safety, and diagnostic efficacy of the radiotracer 68Ga-FC516 in healthy adults and prostate cancer…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Cancer Survivors Program [NA]
A cancer survivors program trial sponsored by Masaryk Memorial Cancer Institute is currently recruiting and involves prostate and breast can…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies [Phase 3]
Phase 3 trial comparing darolutamide with androgen deprivation therapy (ADT) versus placebo with ADT in men with hormone-sensitive prostate …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
A prospective study in Algeria aims to characterize the epidemiological, clinical, diagnostic, and therapeutic features of prostate cancer a…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
A Mayo Clinic-sponsored trial is recruiting to evaluate improvements in dynamic contrast-enhanced MR angiography, perfusion, and non-contras…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4257496 in Participants With Cancer (OMNIRAY) [Phase 1]
Phase 1 clinical trial update for LY4257496 in cancer patients; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients [Phase 2]
A Phase 2 study is planned to observe whether tamoxifen can aid testosterone recovery in medically castrated prostate cancer patients, with …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007) [NA]
A feasibility study evaluating biometric measurements from wearable smartwatch technology to assess vasomotor symptoms in prostate cancer pa…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord [Phase 2]
This is a Phase 2 clinical trial update evaluating the combination of thermal ablation and spine stereotactic radiosurgery for spine metasta…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01) [Phase 1, Phase 2]
This document outlines a two-part clinical trial (Phase 1 dose escalation/expansion followed by Phase 2) of Tulmimetostat and Luxdegalutamid…